February 28, 2017
NEXSTIM PLC FINANCIAL STATEMENT RELEASE 2016
Media
February 28, 2017
Nordic Nanovector ASA – Results for Fourth Quarter and Full Year 2016
February 27, 2017
Strongbridge Biopharma plc to Present at the 37th Annual Cowen and Company Healthcare Conference and the 29th Annual ROTH Conference
February 24, 2017
Company’s CEO Acquires Shares in Oncopeptides
February 24, 2017
Fusion Pharmaceuticals Launches with a $25M USD Series A Financing to Develop Targeted Radiotherapeutics as Cancer Treatments
February 23, 2017
Final Results from NICHE Phase III trial presented at the International Stroke Conference
February 23, 2017
Wilson Theraputics AB (publ) Year-end Report 2016
February 22, 2017
Nordic Nanovector ASA: Invitation to Fourth Quarter and Full Year 2016 Results Presentation and Webcast
February 22, 2017
Trading of Oncopeptides AB (publ) on Nasdaq Stockholm commences today
February 21, 2017
GenSight Biologics Completes Enrollment of REVERSE Phase III Study of GS010 in the treatment of Leber’s Hereditary Optic Neuropathy
